Serving hundreds of leading biopharmaceutical companies globally:

Generated: February 17, 2019

DrugPatentWatch Database Preview

PROLIA Drug Profile

« Back to Dashboard

Summary for Tradename: PROLIA

Patents:	73
Applicants:	1
BLAs:	1
Suppliers: see list	1
Drug Prices:	Drug price information for PROLIA

Pharmacology for PROLIA

Mechanism of Action	RANK Ligand Blocking Activity

US Patents for PROLIA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Sign Up	Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES)	➤ Sign Up	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Sign Up	SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL)	➤ Sign Up	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Sign Up	Fundacio Institut de Recerca Biomedica (IRB Barcelona) (Barcelona, ES) Institucio Catalana de Recerca I Estudis Avancats (Barcelona, ES)	➤ Sign Up	RX	Orphan	search
Amgen	PROLIA	denosumab	INJECTABLE; SUBCUTANEOUS	125320	001	2010-06-01	➤ Sign Up	CONCIEVALVE, LLC (Minneapolis, MN)	➤ Sign Up	RX	Orphan	search
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for PROLIA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Australia	2013289883	➤ Sign Up
New Zealand	535798	➤ Sign Up
China	105837411	➤ Sign Up
New Zealand	500253	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for PROLIA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C01409016/01	Switzerland	➤ Sign Up	PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: SWISSMEDIC 60210 03.08.2010
1090038-9.L	Sweden	➤ Sign Up	PRODUCT NAME: DENOSUMAB; REG. NO/DATE: EU/1/10/618/001 20100526
CA 2010 00031	Denmark	➤ Sign Up
C00951551/01	Switzerland	➤ Sign Up	PRODUCT NAME: DENOSUMABUM; REGISTRATION NO/DATE: SWISSMEDIC 60210 03.08.2010
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte

Harvard Business School

Julphar

McKesson

US Department of Justice

Merck

Chubb

Accenture

Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.